Tower Research Capital »

Lipocine shares owned by Tower Research Capital

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3k 1.2k 2.85
2025-06-30 $2.1k 673 3.16
2025-03-31 $3.9k 1.2k 3.18
2024-12-31 $7.2k 1.5k 4.88
2024-09-30 $4.8k 1.1k 4.49
2024-06-30 $6.4k 772 8.24
2024-03-31 $11k 2.0k 5.20
2023-09-30 $756 254 2.98
2023-06-30 $9.2k 1.8k 5.04